MARKET

SNOA

SNOA

SONOMA PHARMACEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.83
-0.38
-5.27%
After Hours: 6.99 +0.16 +2.34% 19:29 11/24 EST
OPEN
7.01
PREV CLOSE
7.21
HIGH
7.20
LOW
6.72
VOLUME
40.81K
TURNOVER
--
52 WEEK HIGH
19.60
52 WEEK LOW
3.330
MARKET CAP
13.95M
P/E (TTM)
-2.8598
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Sonoma Pharmaceuticals Q2 EPS $0.06 Up From $(0.91) YoY, Sales $5.80M Up From $4.97M YoY
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly earnings of $0.06 per share. This is a 106.59 percent increase over losses of $(0.91) per share from the same period last year. The company reported $5.80 million
Benzinga · 4d ago
Sonoma Pharmaceuticals Reports Second Quarter FY 2021 Financial Results
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2020. It further announced that it had to restate its first quarter financial statements for the quarter ended June 30, 2020 due to material errors.
Business Wire · 4d ago
ATHE, MFGP, FCEL and PAYS among midday movers
Gainers: Phoenix Tree (DNK) +91%.Naked Brand (NAKD) +64%.Kazia Therapeutics (KZIA) +32%.Micro Focus International (MFGP) +32%.BELLUS Health (BLU) +31%.InnSuites Hospitality Trust (IHT) +27%.FuelCell Energy (FCEL) +27%.Ashford Hospitality Trust (AHT) +24%.CIIG Merger (CIIC) +23%.Kodiak Sciences (KOD)
Seekingalpha · 6d ago
Health Canada Ok's Sonoma's disinfectant & sanitizer
Sonoma Pharmaceuticals (SNOA) rises ~14% in premarket, after the company along with its partner, the MicroSafe Group, Dubai, announced that Health Canada has approved Nanocyn Disinfectant & Sanitizer, to be sold into Canada through an interim
Seekingalpha · 09/18 13:06
VALE, AGEN among premarket gainers
Cassava Sciences (SAVA) +27% on insider buying.Immutep (IMMP) +21% on encouraging results from mid-stage TACTI-002 study.ClearOne (CLRO) +13% on insider buying.Sonoma Pharmaceuticals (SNOA) +12% on receiving approval by Health Canada for their patented and trademarked Nanocyn®
Seekingalpha · 09/18 12:13
Sonoma Pharmaceuticals and MicroSafe Group Announce that Health Canada Authorized Nanocyn® Disinfectant & Sanitizer to be Sold in Canada as a Hard-Surface Disinfectant under COVID-19 Interim Measure
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and its partner, the MicroSafe Group, Dubai
Business Wire · 09/17 21:05
Sonoma Pharma +8% on launch of two new products in Australia
Sonoma Pharmaceuticals (SNOA) and partner, Te Arai BioFarma have launched two new products - Nasocyn Nasal Care and Oracyn Oral Care in Australia.Both of these products are based on Sonoma’s patented Microcyn and Microdacyn technology and
Seekingalpha · 09/10 12:44
Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn® Technology Products in Australia – Nasocyn® Nasal Care and Oracyn® Oral Care
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, oral, nasal, and eye care and dermatological conditions, and its New Zealand and Australian partner, Te
Business Wire · 09/09 20:10
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SNOA. Analyze the recent business situations of SONOMA PHARMACEU through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SNOA stock price target is 9.00 with a high estimate of 9.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 27
Institutional Holdings: 237.54K
% Owned: 11.63%
Shares Outstanding: 2.04M
TypeInstitutionsShares
Increased
2
15.02K
New
8
38.88K
Decreased
2
313
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
0.00%
Key Executives
Chief Executive Officer
Amy Trombly
Chief Financial Officer
Jerry Dvonch
Chief Operating Officer/Secretary
Bruce Thornton
Lead Director/Independent Director
Jerry McLaughlin
Independent Director
Sharon Barbari
Independent Director
Jay Birnbaum
Independent Director
Philippe Weigerstorfer
Independent Director
Sharon Surrey Barbari
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SNOA
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets solutions for management of dermatological conditions and advanced tissue care. The Company's product portfolio consists of dermatology, animal health, and advanced tissue care products based upon its Microcyn technology. Its Microcyn technology family of products consists of liquids and gels, which contain small molecule oxychlorine compounds. Its products serve patients across the globe by reducing infections, itch, pain, scarring and inflammatory responses. Its products are sold throughout the United States and internationally.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Sonoma Pharmaceuticals Inc stock information, including NASDAQ:SNOA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNOA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNOA stock methods without spending real money on the virtual paper trading platform.